Sepsis: From pattern to mechanism and back

Critical Reviews in Biomedical Engineering

Volumn 40, Issue 4, 2012, Pages 341-351

  Vodovotz, Yoram ^b,c   An, Gary ^a,b   Namas, Rami A ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Inflammatory response; Mathematical modeling; Sepsis; Septic shock; SIRS

Indexed keywords

CELLULAR BIOLOGY; COMPUTATIONAL MODELING; CONTROL STRUCTURE; INFLAMMATORY RESPONSE; ITERATIVE APPROACH; PHYSIOLOGICAL PROCESS; PHYSIOLOGICAL SIGNALS; SEPSIS; SEPTIC SHOCKS; SIRS;

CYTOLOGY; FORMAL LANGUAGES; MATHEMATICAL MODELS;

PHYSIOLOGY;

ARTICLE; BIOLOGY; CELL INTERACTION; COMPUTER MODEL; CRITICAL ILLNESS; CYTOLOGY; EXPERIMENTATION; HUMAN; LABORATORY TEST; MATHEMATICAL ANALYSIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; SEPSIS; TRANSLATIONAL RESEARCH;

ANIMALS; HUMANS; MODELS, IMMUNOLOGICAL; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 84868321505     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v40.i4.80     Document Type: Article

References (132)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-54.
3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-53.
4. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57(14):1-134.
5. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep. 2001;49(8):1-113.
6. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med. 2003;31(9):2316-23.
7. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340(3):207-14.
8. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 suppl):S109-16.
9. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt BL. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278(3):234-40.
10. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med. 1990;113(3):227-42.
11. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med. 2000;28(11):3599-605.
12. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA. 1995;274(4):338-45.
13. Increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. MMWR Morb Mortal Wkly Rep. 1990;19;39(2):31-4.
14. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101(10):3765-77.
15. Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med. 2010;36(8):1286-98.
16. Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10(5):228-34.
17. Balestra GM, Legrand M, Ince C. Microcirculation and mitochondria in sepsis: getting out of breath. Curr.Opin Anaesthesiol. 2009;22(2):184-90.
18. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776-87.
19. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38(2 suppl):S26-S34.
20. Geroulanos S, Douka ET. Historical perspective of the word sepsis. Intensive Care Med. 2006;32(12):2077.
21. Ewald PW. Evolution of virulence. Infect.Dis.Clin.North Am. 2004;18(1):1-15.
22. Vincent JL. Clinical sepsis and septic shock-definition, diagnosis and management principles. Langenbecks Arch.Surg. 2008;393(6):817-24.
23. Schottmueller H(1914). Wesen und Behandlung der Sepsis. Inn Med 2009;31:257-80.
24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-74.
25. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-6.
26. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-55.
27. Ventetuolo CE, Levy MM. Biomarkers: diagnosis and risk assessment in sepsis. Clin.Chest Med. 2008;29(4):591-603+vii.
28. Claus RA, Otto GP, Deigner HP, Bauer M. Approaching clinical reality: markers for monitoring systemic inflammation and sepsis. Curr Mol Med. 2010;10(2):227-35.
29. Namas R, Zamora R, Namas R, An G, Doyle J, Dick TE, Jacono FJ, Androulakis IP, Chang S, Billiar TR, Kellum JA, Angus DC, Vodovotz Y. Sepsis: Something old, something new, and a systems view. J Crit Care 2012;Jun:27(3):314.e1-11.
30. www.physionet.org 2012.
31. Gang Y, Malik M. Heart rate variability in critical care medicine. Curr Opin Crit Care. 2002;8(5):371-5.
32. Moorman JR, Lake DE, Griffin MP. Heart rate characteristics monitoring for neonatal sepsis. IEEE Trans Biomed Eng 2006;53(1):126-32.
33. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 1996;24(7):1107-16.
34. Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160(2):458-65.
35. Korach M, Sharshar T, Jarrin I, Fouillot JP, Raphael JC, Gajdos P, Annane D. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med. 2001;29(7): 1380-5.
36. Piepoli M, Garrard CS, Kontoyannis DA, Bernardi L. Autonomic control of the heart and peripheral vessels in human septic shock. Intensive Care Med. 1995;21(2):112-9.
37. Fairchild KD, Saucerman JJ, Raynor LL, Sivak JA, Xiao Y, Lake DE, Moorman JR. Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol. 2009;297(4):R1019-27.
38. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17(3):354-81.
39. Kleiger RE, Stein PK, Bigger JT, Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10(1):88-101.
40. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am.J Physiol. 1985;248(1 Pt 2):H151-H153.
41. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit Care Med. 1996;24(7):1117-24.
42. Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med. 2002;9(7):661-70.
43. Chen WL, Kuo CD. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med. 2007;14(5):392-7.
44. Pontet J, Contreras P, Curbelo A, Medina J, Noveri S, Bentancourt S, Migliaro ER. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care. 2003;18(3):156-63.
45. Ahmad S, Ramsay T, Huebsch L, Flanagan S, McDiarmid S, Batkin I, McIntyre L, Sundaresan SR, Maziak DE, Shamji FM, Hebert P, Fergusson D, Tinmouth A, Seely AJ. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS ONE. 2009;4(8):e6642.
46. Magder S. Bench-to-bedside review: ventilatory abnormalities in sepsis. Crit Care 2009;13(1):202-13.
47. Preas HL, Jubran A, Vandivier RW, Reda D, Godin PJ, Banks SM, Tobin MJ, Suffredini AF. Effect of endotoxin on ventilation and breath variability: role of cyclooxygenase pathway. Am J Respir.Crit Care Med. 2001;164(4):620-6.
48. Cancio LC, Batchinsky AI, Salinas J, Kuusela T, Convertino VA, Wade CE, Holcomb JB. Heart-rate complexity for prediction of prehospital lifesaving interventions in trauma patients. J Trauma. 2008;65(4):813-9.
49. www.iccai.org/sci_info_2010.php.
50. An G. Phenomenological issues related to the measurement, mechanisms and manipulation of complex biological systems. Crit Care Med. 2006;34(1):245-6.
51. Hodgin KE, Moss M. The epidemiology of sepsis. Curr Pharm Des. 2008;14(19):1833-9.
52. Chung TP, Laramie JM, Province M, Cobb JP. Functional genomics of critical illness and injury. Crit Care Med. 2002;30(1 suppl):S51-7.
53. Cobb JP, O'Keefe GE. Injury research in the genomic era. Lancet. 2004;363(9426):2076-83.
54. Wurfel MM. Microarray-based analysis of ventilator-induced lung injury. Proc Am Thorac Soc. 2007;4(1):77-84.
55. Winkelman C. Inflammation and genomics in the critical care unit. Crit Care Nurs Clin North Am. 2008;20(2):213-21+vi.
56. Nguyen A, Yaffe MB. Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med. 2003;31(1 suppl):S1-6
57. Bauer M, Reinhart K. Molecular diagnostics of sepsis-where are we today? Int J Med Microbiol. 2010;300(6):411-3.
58. Serkova NJ, Standiford TJ, Stringer KA. The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical Illnesses. Am J Respir Crit Care Med. 2011;Sep 15;184(6):647-55.
59. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF, Large Scale Collab Res Program. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032-7.
60. Liu T, Qian WJ, Gritsenko MA, Xiao W, Moldawer LL, Kaushal A, Monroe ME, Varnum SM, Moore RJ, Purvine SO, Maier RV, Davis RW, Tompkins RG, Camp DG, Smith RD. High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics. 2006;5(10):1899-913.
61. McDunn JE, Husain KD, Polpitiya AD, Burykin A, Ruan J, Li Q, Schierding W, Lin N, Dixon D, Zhang W, Coopersmith CM, Dunne WM, Colonna M, Ghosh BK, Cobb JP. Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS ONE. 2008;3(2): e1564.
62. Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, Maier RV, Moldawer LL, Moore EE, Harbrecht BG, Pelak K, Cuschieri J, Herndon DN, Jeschke MG, Finnerty CC, Brownstein BH, Hennessy L, Mason PH, Tompkins RG. A genomic score prognostic of outcome in trauma patients. Mol Med. 2009;15(7-8):220-7.
63. Cobb JP, Moore EE, Hayden DL, Minei JP, Cuschieri J, Yang J, Li Q, Lin N, Brownstein BH, Hennessy L, Mason PH, Schierding WS, Dixon DJ, Tompkins RG, Warren HS, Schoenfeld DA, Maier RV. Validation of the riboleukogram to detect ventilator-associated pneumonia after severe injury. Ann Surg. 2009;250(4):531-9.
64. Qian WJ, Petritis BO, Kaushal A, Finnerty CC, Jeschke MG, Monroe ME, Moore RJ, Schepmoes AA, Xiao W, Moldawer LL, Davis RW, Tompkins RG, Herndon DN, Camp DG, Smith RD. Plasma proteome response to severe burn injury revealed by 180-labeled universal reference-based quantitative proteomics. J Proteome Res. 2010;9(9):4779-89.
65. Zhou B, Xu W, Herndon D, Tompkins R, Davis R, Xiao W, Wong WH, Toner M, Warren HS, Schoenfeld DA, Rahme L, McDonald-Smith GP, Hayden D, Mason P, Fagan S, Yu YM, Cobb JP, Remick DG, Mannick JA, Lederer JA, Gamelli RL, Silver GM, West MA, Shapiro MB, Smith R, Camp DG, Qian W, Storey J, Mindrinos M, Tibshirani R, Lowry S, Calvano S, Chaudry I, West MA, Cohen M, Moore EE, Johnson J, Moldawer LL, Baker HV, Efron PA, Balis UG, Billiar TR, Ochoa JB, Sperry JL, Miller-Graziano CL, De AK, Bankey PE, Finnerty CC, Jeschke MG, Minei JP, Arnoldo BD, Hunt JL, Horton J, Cobb JP, Brownstein B, Freeman B, Maier RV, Nathens AB, Cuschieri J, Gibran N, Klein M, O'keefe G. Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A. 2010;107(22):9923-8.
66. Mi Q, Constantine G, Ziraldo C, Solovyev A, Torres A, Namas R, Bentley T, Billiar TR, Zamora R, Puyana JC, Vodovotz Y. A dynamic view of trauma/hemorrhageinduced inflammation in mice: Principal drivers and networks. PLoS ONE. 2011;6:e19424.
67. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol. 2008;4:1-6.
68. Foteinou PT, Yang E, Androulakis IP. Networks, biology and systems engineering: a case study in inflammation. Comput Chem Eng. 2009;33(12):2028-41.
69. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Translational potential of systems-based models of inflammation. Clin Transl Sci. 2009;2(1):85-9.
70. Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G. Mechanistic simulations of inflammation: Current state and future prospects. Math Biosci. 2009;217:1-10.
71. Vodovotz Y, An G. Yan Q, editors. Systems biology in drug discovery and development: methods and protocols. Totowa, NJ: Springer Science & Business Media; 2009; p. 181-201.
72. Vodovotz Y, Constantine G, Faeder J, Mi Q, Rubin J, Sarkar J, Squires R, Okonkwo DO, Gerlach J, Zamora R, Luckhart S, Ermentrout B, An G. Translational systems approaches to the biology of inflammation and healing. Immunopharmacol Immunotoxicol. 2010;32:181-95.
73. Vodovotz Y. Translational systems biology of inflammation and healing. Wound Repair Regen. 2010;18(1):3-7.
74. Mi Q, Li NYK, Ziraldo C, Ghuma A, Mikheev M, Squires R, Okonkwo DO, Verdolini Abbott K, Constantine G, An G, Vodovotz Y. Translational systems biology of inflammation: Potential applications to personalized medicine. Personalized Med. 2010;7:549-59.
75. An G, Bartels J, Vodovotz Y. In silico augmentation of the drug development pipeline: Examples from the study of acute inflammation. Drug Dev Res. 2010;72:1-14.
76. Vincent JL, Abraham E. The last 100 years of sepsis. Am J Respir Crit Care Med. 2006;173(3):256-63.
77. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2009;37(1):291-304.
78. Vodovotz Y, Chow CC, Bartels J, Lagoa C, Prince JM, Levy RM, Kumar R, Day J, Rubin J, Constantine G, Billiar TR, Fink MP, Clermont G. In silico models of acute inflammation in animals. Shock. 2006;26(3):235-44.
79. Mi Q, Li NYK, Ziraldo C, Ghuma A, Mikheev M, Squires R, Okonkwo DO, Verdolini Abbott K, Constantine G, An G, Vodovotz Y. Translational systems biology of inflammation: Potential applications to personalized medicine. Personalized Med. 2010;7:549-59.
80. Namas R, Ghuma A, Torres A, Polanco P, Gomez H, Barclay D, Gordon L, Zenker S, Kim HK, Hermus L, Zamora R, Rosengart MR, Clermont G, Peitzman A, Billiar TR, Ochoa J, Pinsky MR, Puyana JC, Vodovotz Y. An adequately robust early TNF-α response is a hallmark of survival following trauma/hemorrhage. PLoS ONE. 2009;4(12):e8406.
81. Rose S, Marzi I. Mediators in polytrauma-pathophysiological significance and clinical relevance. Langenbecks Arch Surg. 1998;383(3-4):199-208.
82. Smith RM, Giannoudis PV. Trauma and the immune response. J.R.Soc.Med. 1998;91(8):417-20.
83. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138-50.
84. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin. 2005;21(2):177-96.
85. Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 2001;29(7 suppl):S99-106.
86. Jarrar D, Chaudry IH, Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). Int J Mol Med. 1999;4(6):575-83.
87. Crouser E, Exline M, Knoell D, Wewers MD. Sepsis: links between pathogen sensing and organ damage. Curr. Pharm.Des 2008;14(19):1840-52.
88. Bone RC. Why sepsis trials fail. JAMA.1996;276(7):565-6.
89. Vodovotz Y, Clermont G, Chow C, An G. Mathematical models of the acute inflammatory response. Curr.Opin. Crit Care. 2004;10(5):383-90.
90. Neugebauer E., Willy C, Sauerland S. Complexity and non-linearity in shock research: reductionism or synthesis? Shock. 2001;16(4):252-8.
91. Tjardes T, Neugebauer E. Sepsis research in the next millennium: concentrate on the software rather than the hardware. Shock. 2002;17(1):1-8.
92. Buchman TG, Cobb JP, Lapedes AS, Kepler TB. Complex systems analysis: a tool for shock research. Shock. 2001;16(4):248-51.
93. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med. 2000;28(7):2193-200.
94. An G. Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. Shock. 2001;16(4):266-73.
95. Kitano H. Systems biology: a brief overview. Science. 2002;295(5560):1662-4.
96. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol. 2008;4(4):e1000014
97. Cohen MJ, Grossman AD, Morabito D, Knudson MM, Butte AJ, Manley GT. Identification of complex metabolic states in critically injured patients using bioinformatic cluster analysis. Crit Care. 2010;14(1):R10-20.
98. An G. In-silico experiments of existing and hypothetical cytokine-directed clinical trials using agent based modeling. Crit Care Med. 2004;32:2050-60.
99. Vodovotz Y. Deciphering the complexity of acute inflammation using mathematical models. Immunol Res. 2006;36(1-3):237-45.
100. http://commonfund.nih.gov/aboutroadmap.aspx.
101. An G. Translational systems biology using an agent based approach for dynamic knowledge representation: An evolutionary paradigm for biomedical research. Wound Rep Reg. 2010;18:8-12.
102. An G. Closing the scientific loop: Bridging correlation and causality in the petaflop age. Sci Transl Med. 2010;2:41ps34.
103. Vodovotz Y, Clermont G, Hunt CA, Lefering R, Bartels J, Seydel R, Hotchkiss J, Ta'asan S, Neugebauer E, An G. Evidence-based modeling of critical illness: an initial consensus from the Society for Complexity in Acute Illness. J Crit Care. 2007;22(1):77-84.
104. An G, Faeder J, Vodovotz Y. Translational systems biology: Introduction of an engineering approach to the pathophysiology of the burn patient. J Burn Care Res. 2008;29:277-85.
105. An G, Mi Q, Dutta-Moscato J, Solovyev A, Vodovotz Y. Agent-based models in translational systems biology. WIRES. 2009;1:159-71.
106. Kumar R, Clermont G, Vodovotz Y, Chow CC. The dynamics of acute inflammation. J.Theoretical Biol. 2004;230:145-55.
107. An G, Faeder JR. Detailed qualitative dynamic knowledge representation using a BioNetGen model of TLR-4 signaling and preconditioning. Math Biosci. 2009;217:53-63.
108. An G. A model of TLR4 signaling and tolerance using a qualitative, particle event-based method: Introduction of Spatially Configured Stochastic Reaction Chambers (SCSRC). Math Biosci. 2009;217:43-52.
109. Gibbs JB. Mechanism-based target identification and drug discovery in cancer research. Science. 2000;287(5460): 1969-73.
110. Faeder JR, Hlavacek WS, Reischl I, Blinov ML, Metzger H, Redondo A, Wofsy C, Goldstein B. Investigation of early events in Fc epsilon RI-mediated signaling using a detailed mathematical model. J Immunol. 2003;170(7):3769-81.
111. Rivière B, Epshteyn Y, Swigon D, Vodovotz Y. A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with toll-like receptor 4 demonstrates inherent preconditioning behavior. Math Biosci. 2009;217:19-26.
112. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, Gallo D, Betten B, Bartels J, Constantine G, Fink MP, Billiar TR, Vodovotz Y. The acute inflammatory response in diverse shock states. Shock. 2005;24:74-84.
113. Reynolds A, Rubin J, Clermont G, Day J, Vodovotz Y, Ermentrout GB. A reduced mathematical model of the acute inflammatory response: I Derivation of model and analysis of anti-inflammation. J Theor Biol. 2006;242:220-36.
114. Day J, Rubin J, Vodovotz Y, Chow CC, Reynolds A, Clermont G. A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration: J Theor Biol. 2006;242:237-56.
115. Torres A, Bentley T, Bartels J, Sarkar J, Barclay D, Namas R, Constantine G, Zamora R, Puyana JC, Vodovotz Y. Mathematical modeling of post-hemorrhage inflammation in mice Studies using a novel, computercontrolled, closed-loop hemorrhage apparatus. Shock 2009;32:172-8.
116. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci. 2009;217:27-42.
117. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. In silico simulation of corticosteroids effect on an NFkB-dependent physicochemical model of systemic inflammation. PLoS ONE. 2009;4(3):e4706.
118. Kumar R, Chow CC, Bartels J, Clermont G, Vodovotz Y. A mathematical simulation of the inflammatory response to anthrax infection. Shock 2008;29:104-11.
119. Arciero J, Rubin J, Upperman J, Vodovotz Y, Ermentrout GB. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS ONE. 2010;5:e10066
120. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med. 2009;15(6):641-8.
121. Prince JM, Levy RM, Bartels J, Baratt A, Kane JM, III, Lagoa C, Rubin J, Day J, Wei J, Fink MP, Goyert SM, Clermont G, Billiar TR, Vodovotz Y. In silico and in vivo approach to elucidate the inflammatory complexity of CD 14-deficient mice. Mol Med. 2006;12:88-96.
122. Lagoa CE, Bartels J, Baratt A, Tseng G, Clermont G, Fink MP, Billiar TR, Vodovotz Y. The role of initial trauma in the host's response to injury and hemorrhage: Insights from a comparison of mathematical simulations and hepatic transcriptomic analysis. Shock. 2006;26:592-600.
123. Daun S, Rubin J, Vodovotz Y, Roy A, Parker R, Clermont G. An ensemble of models of the acute inflammatory response to bacterial lipopolysaccharide in rats: results from parameter space reduction. J Theor Biol. 2008;253:843-53.
124. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics. 2010;42(1):5-19.
125. Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C. In silico design of clinical trials: a method coming of age. Crit Care Med. 2004;32(10):2061-70.
126. Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T, Hirasawa H. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock. 2007;28(5):549-53.
127. Fokas AS, Halliwell J, Kibble T, Zegarlinski B. editors. Highlights of Mathematical Physics. Providence, RI: American Mathematical Society; 2002.
128. Kot M. Elements of Mathematical Ecology. Cambridge, UK: Cambridge University Press; 2001.
129. Baskes MI. The status role of modeling and simulation in materials science and engineering. Curr Opin Solid State Mater Sci. 1999;4(3):273-7.
130. van der Lee J, De Windt L. Present state and future directions of modeling of geochemistry in hydrogeological systems. J Contam Hydrol. 2001;47(2-4):265-82.
131. Buchman TG. In vivo, in vitro, in silico. Crit.Care Med. 2004;32(10):2159-60.
132. Marshall JC. Through a glass darkly: the brave new world of in silico modeling. Crit Care Med. 2004;32(10):2157-9.